The nuclear decommissioning services market involves activities to safely dismantle or decontaminate nuclear facilities. It provides dismantling, demolition and waste management services of retired nuclear power plants and research reactors. Nuclear decommissioning slows down the growth of radioactive inventory and clears the site for other uses. It helps reduce operational and maintenance costs of abandoned nuclear facilities. The services deal with decommissioning strategy planning, radiological characterization, dismantling and segmentation, transportation and storage of radioactive waste.
Global Nuclear Decommissioning Services Market is estimated to be valued at US$ 230.1 Mn in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the nuclear decommissioning services are Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., and STEMCELL Technologies.
Growing for clean and safe sources of energy generation is expected to drive the Nuclear Decommissioning Services Market Growth during the forecast period. With rising number of retiring nuclear power plants, demand for nuclear decommissioning services is anticipated to increase significantly over the coming years. Several countries worldwide are undertaking large nuclear decommissioning projects which is further expected to accelerate the market expansion on the global level.
Get More Insights on- Nuclear Decommissioning Services Market
